NIC
PTLA

Northwest Investment Counselors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Northwest Investment Counselors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-99
Closed -$3K – 543
2019
Q3 		$3K Buy
+99
New +$2.78K ﹤0.01% 489

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Northwest Investment Counselors's PTLA Position: Q4 2019 in Review

Northwest Investment Counselors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2019, closing a stake of 99 shares — an estimated $3K sold.

Northwest Investment Counselors first reported a position in PTLA in Q3 2019 and held it in 1 quarter. The position peaked at $3K in Q3 2019. 224 funds tracked by Wall St. Rank hold PTLA as of Q4 2019.

  • Northwest Investment Counselors reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Northwest Investment Counselors sold 99 Portola Pharmaceuticals, Inc. shares in Q4 2019, an estimated $3K.
  • Northwest Investment Counselors first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 1 quarter.
  • Northwest Investment Counselors's Portola Pharmaceuticals, Inc. position peaked at $3K in Q3 2019.
  • 224 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2019.

Based on Northwest Investment Counselors's 13F filing for Q4 2019, filed 27 Jan 2020.